1164 related articles for article (PubMed ID: 22521895)
1. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
Maes M; Twisk FN; Johnson C
Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
Maes M; Twisk FN; Ringel K
Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
[TBL] [Abstract][Full Text] [Related]
3. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
Maes M; Twisk FN; Kubera M; Ringel K
J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140
[TBL] [Abstract][Full Text] [Related]
4. In myalgic encephalomyelitis/chronic fatigue syndrome, increased autoimmune activity against 5-HT is associated with immuno-inflammatory pathways and bacterial translocation.
Maes M; Ringel K; Kubera M; Anderson G; Morris G; Galecki P; Geffard M
J Affect Disord; 2013 Sep; 150(2):223-30. PubMed ID: 23664637
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
Maes M
Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898
[TBL] [Abstract][Full Text] [Related]
6. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Morris G; Maes M
Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
[TBL] [Abstract][Full Text] [Related]
7. A new case definition of Neuro-Inflammatory and Oxidative Fatigue (NIOF), a neuroprogressive disorder, formerly known as chronic fatigue syndrome or Myalgic Encephalomyelitis: results of multivariate pattern recognition methods and external validation by neuro-immune biomarkers.
Maes M
Neuro Endocrinol Lett; 2015; 36(4):320-9. PubMed ID: 26454487
[TBL] [Abstract][Full Text] [Related]
8. Problems in defining post-exertional malaise.
Jason LA; Evans M; So S; Scott J; Brown A
J Prev Interv Community; 2015; 43(1):20-31. PubMed ID: 25584525
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of myalgic encephalomyelitis: where are we now?
Maes M; Anderson G; Morris G; Berk M
Expert Opin Med Diagn; 2013 May; 7(3):221-5. PubMed ID: 23480562
[TBL] [Abstract][Full Text] [Related]
10. Increased IgA responses to the LPS of commensal bacteria is associated with inflammation and activation of cell-mediated immunity in chronic fatigue syndrome.
Maes M; Twisk FN; Kubera M; Ringel K; Leunis JC; Geffard M
J Affect Disord; 2012 Feb; 136(3):909-17. PubMed ID: 21967891
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.
Maes M; Leunis JC; Geffard M; Berk M
Neuro Endocrinol Lett; 2014; 35(6):445-53. PubMed ID: 25433843
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of activation antigens on CD8+ T lymphocytes in Myalgic Encephalomyelitis/chronic fatigue syndrome: inverse associations with lowered CD19+ expression and CD4+/CD8+ ratio, but no associations with (auto)immune, leaky gut, oxidative and nitrosative stress biomarkers.
Maes M; Bosmans E; Kubera M
Neuro Endocrinol Lett; 2015; 36(5):439-46. PubMed ID: 26707044
[TBL] [Abstract][Full Text] [Related]
13. The evidence base for physiotherapy in myalgic encephalomyelitis/chronic fatigue syndrome when considering post-exertional malaise: a systematic review and narrative synthesis.
Wormgoor MEA; Rodenburg SC
J Transl Med; 2021 Jan; 19(1):1. PubMed ID: 33397399
[TBL] [Abstract][Full Text] [Related]
14. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome.
Buchwald D; Wener MH; Pearlman T; Kith P
J Rheumatol; 1997 Feb; 24(2):372-6. PubMed ID: 9034999
[TBL] [Abstract][Full Text] [Related]
15. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A
Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625
[TBL] [Abstract][Full Text] [Related]
16. Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue Syndrome: from clinical-consensus to evidence-based case definitions.
Morris G; Maes M
Neuro Endocrinol Lett; 2013; 34(3):185-99. PubMed ID: 23685416
[TBL] [Abstract][Full Text] [Related]
17. Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression.
Maes M; Mihaylova I; Kubera M; Ringel K
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):169-75. PubMed ID: 21945535
[TBL] [Abstract][Full Text] [Related]
18. "Functional" or "psychosomatic" symptoms, e.g. a flu-like malaise, aches and pain and fatigue, are major features of major and in particular of melancholic depression.
Maes M
Neuro Endocrinol Lett; 2009; 30(5):564-73. PubMed ID: 20035251
[TBL] [Abstract][Full Text] [Related]
19. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
[TBL] [Abstract][Full Text] [Related]
20. Lower whole blood glutathione peroxidase (GPX) activity in depression, but not in myalgic encephalomyelitis / chronic fatigue syndrome: another pathway that may be associated with coronary artery disease and neuroprogression in depression.
Maes M; Mihaylova I; Kubera M; Uytterhoeven M; Vrydags N; Bosmans E
Neuro Endocrinol Lett; 2011; 32(2):133-40. PubMed ID: 21552194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
